Looking for Grand Rounds U.S. 2026?Access the 3rd Grand Rounds U.S. — Seattle Now

Interested in learning more about becoming a Presenting Company for Grand Rounds in Houston?

⁠Bridging Academia and Industry for Breakthrough Innovation

Join top VCs, academic innovators and biopharma leaders at the 4th BioCentury Grand Rounds – U.S in Houston, TX, April 12-14, 2027.

Examine the latest advances in disease biology, therapeutic modalities and enabling technologies with the experts shaping the future of medicine

Explore how to make R&D investible with experienced company-builders and early-stage investors

Debate how to overcome key bottlenecks in translation to bring breakthrough discoveries into the clinic

Schedule partnering meetings with VCs, pharma executives and leading academics

Sponsorship Opportunities:Highlight Your Thought Leadership

Why Should I Attend?

BioCentury Grand Rounds is a science-focused meeting bringing together academia, pharma, VC and biotech leaders to address translational bottlenecks and unlock breakthroughs at the academia-industry interface.

Find opportunities in groundbreaking research to build your portfolio and pipelines.
Meet the investors and partners who can catalyze the translation of your discoveries into medicine.

Network, partner and debate with:

  • VCs and PEs
  • Biopharma R&D and BD&L Leaders
  • Biotech C-Suite
  • Academic Innovators
  • Financial Dealmakers

Share your Story on Stage

Are you a biotech with cutting-edge innovation? Join the Presenting Company Class of 2027 to increase your visibility and drive partnering requests. Limited space - submit your nominations today.

Apply to Present

Share your Science

Showcase your cutting-edge translational science to top-tier investors and biopharma executives. Get in the room with the right people who can accelerate the path between your laboratory discoveries and the development of value-creating medicines.

Learn More

Deliver Thought Leadership

Share your insights, elevate your brand and position yourself as a peer in BioCentury's network of biopharma decision-makers.

Learn More